Huysmans Michaël, Bronckaers Marc, Schillebeeckx Charlotte, Servaes Dirk
a Department of General Surgery , AZ Turnhout , Turnhout , Belgium.
Acta Chir Belg. 2017 Oct;117(5):308-311. doi: 10.1080/00015458.2017.1328767. Epub 2017 Jun 13.
The objective of this study was to analyze the incidence and treatment options of occult cancer or atypical lesions found in the histopathological examination of reduction mammoplasty (RM) specimens. The role of preoperative mammography and systematic histopathological examination are discussed.
We performed a retrospective single-center database review of all patients who underwent a RM between January 2005 and December 2014. Preoperative examination, histopathological findings and follow-up were documented.
A total of 1045 patients underwent RM, of which 97% were bilateral (1021). All patients received a mammography and routine clinical examination to exclude cancer preoperatively. The overall mean patient age was 40.2 years (14.2-73.4). A total of 19 patients (1.18%) had significant histopathological findings, all of whom were over 40 years of age. There were 4 incidental carcinomas (0.38%), of which 2 were DCIS (0.19%) and 2 invasive ductal carcinomas (0.19%).
Incidence of postoperative diagnosis of occult breast cancer in RM specimens remains low, but poses significant therapeutic challenges. While emphasis should lay on preoperative diagnostics, routine histological analysis of RM specimens is recommended.
本研究旨在分析在缩乳术(RM)标本的组织病理学检查中发现的隐匿性癌症或非典型病变的发生率及治疗选择。并探讨术前乳腺X线摄影和系统组织病理学检查的作用。
我们对2005年1月至2014年12月期间所有接受RM手术的患者进行了一项回顾性单中心数据库审查。记录术前检查、组织病理学结果和随访情况。
共有1045例患者接受了RM手术,其中97%为双侧手术(1021例)。所有患者术前均接受了乳腺X线摄影和常规临床检查以排除癌症。患者的总体平均年龄为40.2岁(14.2 - 73.4岁)。共有19例患者(1.18%)有显著的组织病理学发现,所有这些患者均超过40岁。有4例偶然癌(0.38%),其中2例为导管原位癌(DCIS,0.19%),2例为浸润性导管癌(0.19%)。
RM标本中隐匿性乳腺癌的术后诊断发生率仍然较低,但带来了重大的治疗挑战。虽然应强调术前诊断,但建议对RM标本进行常规组织学分析。